Recent Updates
Recently added Catalysts
MYGN Positive Sentiment Score: 70/100

Myriad Genetics to Participate in Goldman Sachs Healthcare Conference

Wednesday, June 7, 2023 1 min read
Key Takeaway: Myriad Genetics, a leader in genetic testing and precision medicine, will participate in the 44th Annual Goldman Sachs Global Healthcare Conference. CEO Paul J. Diaz is scheduled to take part in a fireside chat on June 13, 2023, at 2:00 p.m. PT. The conversation will be available for replay on Myriad's investor relations website, which aims to enhance communication with investors and stakeholders. This event underscores Myriad's commitment to advancing health and well-being through genetic insights.

Market Sentiment Analysis

POSITIVE FACTORS

  • Myriad Genetics is actively participating in a major healthcare conference.
  • The event will feature a discussion led by the CEO, enhancing visibility.
  • The replay of the chat will be accessible on their investor relations website.

Full Press Release Details

SALT LAKE CITY, June 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and CEO, will participate in the 44th Annual Goldman Sachs Global Healthcare Conference with a fireside chat on Tuesday, June 13, 2023 at 2:00 p.m. PT.
A replay of the fireside chat will be available on the investor relations section of Myriad’s website at www.myriad.com.
About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.
Media Contact: Investor Contact:
Glenn Farrell Matt Scalo
(385) 318-3718 (801) 584-3532
PR@myriad.com IR@myriad.com

Tags

Healthcare conference

Frequently Asked Questions

When will Myriad Genetics' fireside chat take place?

The fireside chat is scheduled for June 13, 2023, at 2:00 p.m. PT.

Where can I watch the replay of the fireside chat?

The replay will be available in the investor relations section of Myriad’s website.

What does Myriad Genetics specialize in?

Myriad Genetics specializes in genetic testing and precision medicine to improve health.

What types of tests does Myriad offer?

Myriad provides genetic tests that assess disease risk and guide treatment decisions.

How can I contact Myriad Genetics?

You can contact Myriad Genetics through their media and investor contacts listed online.

Tags: MYGN Viatris Investor Conferences Healthcare Myriad Genetics healthcare conference Goldman Sachs genetic testing precision medicine
Last updated: Jun 7, 2023